 Lisa Cicutto
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 56 | 2024 | 1774 | 5.080 |
Why?
| | School Health Services | 16 | 2024 | 221 | 4.910 |
Why?
| | School Nursing | 3 | 2018 | 33 | 1.460 |
Why?
| | Patient Education as Topic | 14 | 2015 | 771 | 1.060 |
Why?
| | Needs Assessment | 4 | 2024 | 401 | 0.920 |
Why?
| | Ontario | 20 | 2011 | 96 | 0.900 |
Why?
| | Nurses, Public Health | 2 | 2014 | 5 | 0.830 |
Why?
| | Disease Management | 6 | 2018 | 650 | 0.830 |
Why?
| | Evidence-Based Practice | 3 | 2016 | 229 | 0.790 |
Why?
| | Community Health Services | 5 | 2018 | 231 | 0.730 |
Why?
| | Program Development | 5 | 2018 | 368 | 0.690 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 5 | 2018 | 919 | 0.670 |
Why?
| | Social Determinants of Health | 1 | 2024 | 305 | 0.610 |
Why?
| | Schools | 9 | 2022 | 450 | 0.590 |
Why?
| | Colorado | 9 | 2024 | 4558 | 0.540 |
Why?
| | Self Care | 6 | 2016 | 389 | 0.540 |
Why?
| | Child | 33 | 2024 | 22599 | 0.530 |
Why?
| | Competency-Based Education | 1 | 2016 | 81 | 0.470 |
Why?
| | Particulate Matter | 1 | 2018 | 337 | 0.450 |
Why?
| | Respiratory Therapy | 1 | 2015 | 25 | 0.450 |
Why?
| | Frailty | 1 | 2018 | 200 | 0.430 |
Why?
| | Nurse's Role | 1 | 2016 | 149 | 0.430 |
Why?
| | Primary Health Care | 6 | 2014 | 1730 | 0.410 |
Why?
| | Attitude to Health | 4 | 2007 | 431 | 0.410 |
Why?
| | Practice Guidelines as Topic | 7 | 2016 | 1569 | 0.400 |
Why?
| | Ambulatory Care | 1 | 2018 | 607 | 0.390 |
Why?
| | Anaphylaxis | 2 | 2011 | 102 | 0.390 |
Why?
| | Humans | 74 | 2024 | 144665 | 0.380 |
Why?
| | Health Personnel | 3 | 2016 | 746 | 0.380 |
Why?
| | Rural Health Services | 1 | 2014 | 139 | 0.360 |
Why?
| | Medical Records | 4 | 2009 | 191 | 0.350 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 341 | 0.350 |
Why?
| | Emergency Service, Hospital | 5 | 2018 | 2325 | 0.340 |
Why?
| | Health Services Accessibility | 5 | 2024 | 1098 | 0.310 |
Why?
| | Hospitalization | 3 | 2018 | 2446 | 0.310 |
Why?
| | Bronchodilator Agents | 5 | 2021 | 184 | 0.300 |
Why?
| | Occupational Diseases | 1 | 2011 | 165 | 0.300 |
Why?
| | Child Care | 1 | 2009 | 36 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2015 | 1406 | 0.290 |
Why?
| | Adolescent | 20 | 2024 | 22405 | 0.290 |
Why?
| | Cost of Illness | 2 | 2008 | 322 | 0.270 |
Why?
| | Plagiarism | 1 | 2008 | 3 | 0.270 |
Why?
| | Female | 38 | 2024 | 78301 | 0.270 |
Why?
| | Population Surveillance | 1 | 2011 | 484 | 0.270 |
Why?
| | Hotlines | 1 | 2007 | 32 | 0.270 |
Why?
| | Anti-Asthmatic Agents | 7 | 2009 | 253 | 0.260 |
Why?
| | Observer Variation | 1 | 2008 | 355 | 0.250 |
Why?
| | Child, Preschool | 13 | 2024 | 11789 | 0.250 |
Why?
| | Male | 36 | 2024 | 72425 | 0.250 |
Why?
| | Public Health Nursing | 1 | 2006 | 5 | 0.250 |
Why?
| | Education, Medical, Continuing | 2 | 2005 | 133 | 0.240 |
Why?
| | Disease Progression | 3 | 2018 | 2847 | 0.240 |
Why?
| | Documentation | 1 | 2008 | 198 | 0.240 |
Why?
| | Public Health Practice | 1 | 2006 | 63 | 0.230 |
Why?
| | Program Evaluation | 4 | 2018 | 941 | 0.230 |
Why?
| | Education, Professional | 1 | 2005 | 18 | 0.230 |
Why?
| | Guidelines as Topic | 2 | 2021 | 267 | 0.220 |
Why?
| | Lung Transplantation | 2 | 2007 | 329 | 0.210 |
Why?
| | Specialization | 1 | 2005 | 136 | 0.210 |
Why?
| | Recurrence | 1 | 2007 | 1136 | 0.210 |
Why?
| | Health Care Costs | 1 | 2008 | 425 | 0.210 |
Why?
| | Certification | 1 | 2005 | 118 | 0.210 |
Why?
| | Respiratory Sounds | 1 | 2024 | 103 | 0.200 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2024 | 133 | 0.200 |
Why?
| | Adult | 27 | 2018 | 40486 | 0.200 |
Why?
| | Breath Tests | 1 | 2004 | 77 | 0.200 |
Why?
| | Pilot Projects | 3 | 2024 | 1886 | 0.200 |
Why?
| | Clinical Competence | 2 | 2016 | 1237 | 0.200 |
Why?
| | Vulnerable Populations | 1 | 2024 | 175 | 0.190 |
Why?
| | Quality of Life | 5 | 2013 | 3183 | 0.190 |
Why?
| | Biomedical Research | 2 | 2023 | 712 | 0.180 |
Why?
| | Nebulizers and Vaporizers | 2 | 2015 | 62 | 0.180 |
Why?
| | Registries | 1 | 2011 | 2392 | 0.180 |
Why?
| | Awards and Prizes | 1 | 2023 | 72 | 0.180 |
Why?
| | Delphi Technique | 1 | 2024 | 330 | 0.180 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 93 | 0.180 |
Why?
| | Employment | 1 | 2004 | 184 | 0.180 |
Why?
| | Organizational Case Studies | 2 | 2016 | 68 | 0.180 |
Why?
| | Sputum | 1 | 2004 | 308 | 0.180 |
Why?
| | Social Support | 4 | 2011 | 650 | 0.180 |
Why?
| | Monitoring, Physiologic | 1 | 2004 | 288 | 0.170 |
Why?
| | Depression | 1 | 2011 | 1561 | 0.170 |
Why?
| | Albuterol | 1 | 2021 | 73 | 0.170 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 1180 | 0.170 |
Why?
| | Parents | 3 | 2024 | 1395 | 0.170 |
Why?
| | Health Services | 3 | 2013 | 114 | 0.160 |
Why?
| | Bronchial Neoplasms | 1 | 2000 | 15 | 0.160 |
Why?
| | Surveys and Questionnaires | 11 | 2015 | 6041 | 0.160 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2000 | 17 | 0.160 |
Why?
| | Adaptation, Psychological | 2 | 2010 | 718 | 0.160 |
Why?
| | Lung Diseases | 2 | 2022 | 781 | 0.160 |
Why?
| | Societies, Medical | 1 | 2024 | 890 | 0.150 |
Why?
| | Health Equity | 1 | 2022 | 132 | 0.150 |
Why?
| | Family | 3 | 2018 | 685 | 0.150 |
Why?
| | Absenteeism | 3 | 2018 | 52 | 0.150 |
Why?
| | Connecticut | 1 | 2018 | 25 | 0.140 |
Why?
| | Population | 1 | 2018 | 30 | 0.140 |
Why?
| | Hypersensitivity | 2 | 2011 | 253 | 0.140 |
Why?
| | Case Management | 1 | 2018 | 68 | 0.140 |
Why?
| | Middle Aged | 15 | 2018 | 35968 | 0.140 |
Why?
| | Health Policy | 1 | 2021 | 398 | 0.140 |
Why?
| | Health Services Needs and Demand | 2 | 2011 | 276 | 0.130 |
Why?
| | Students | 2 | 2014 | 657 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 4 | 2000 | 1360 | 0.130 |
Why?
| | Qualitative Research | 2 | 2024 | 1668 | 0.130 |
Why?
| | Pulmonary Medicine | 3 | 2024 | 78 | 0.120 |
Why?
| | Nursing Education Research | 1 | 2016 | 43 | 0.120 |
Why?
| | Occupational Exposure | 2 | 2011 | 355 | 0.120 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 504 | 0.120 |
Why?
| | Aged | 11 | 2018 | 25955 | 0.120 |
Why?
| | Biomarkers | 2 | 2024 | 4261 | 0.110 |
Why?
| | Patient Participation | 1 | 1999 | 428 | 0.110 |
Why?
| | Education, Graduate | 1 | 2015 | 36 | 0.110 |
Why?
| | Mass Screening | 1 | 2024 | 1348 | 0.110 |
Why?
| | Research Personnel | 2 | 2015 | 185 | 0.110 |
Why?
| | Urban Population | 1 | 2018 | 493 | 0.110 |
Why?
| | Information Dissemination | 2 | 2015 | 222 | 0.110 |
Why?
| | Health Education | 2 | 2009 | 345 | 0.110 |
Why?
| | Administration, Inhalation | 2 | 2015 | 570 | 0.100 |
Why?
| | Epinephrine | 2 | 2011 | 154 | 0.100 |
Why?
| | Education, Continuing | 1 | 2014 | 41 | 0.100 |
Why?
| | Interviews as Topic | 3 | 2024 | 905 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1262 | 0.100 |
Why?
| | Rural Population | 1 | 2018 | 657 | 0.100 |
Why?
| | Diabetes Complications | 1 | 2015 | 223 | 0.100 |
Why?
| | Drug Utilization | 1 | 2013 | 167 | 0.090 |
Why?
| | Health Services Research | 1 | 2015 | 392 | 0.090 |
Why?
| | Universities | 1 | 2015 | 452 | 0.090 |
Why?
| | Severity of Illness Index | 4 | 2008 | 2922 | 0.090 |
Why?
| | Mentors | 3 | 2023 | 214 | 0.090 |
Why?
| | Motivation | 3 | 2007 | 601 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 265 | 0.090 |
Why?
| | Activities of Daily Living | 2 | 2006 | 441 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1322 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2024 | 541 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2018 | 736 | 0.080 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 335 | 0.080 |
Why?
| | General Surgery | 1 | 2013 | 206 | 0.080 |
Why?
| | Medication Adherence | 1 | 2015 | 540 | 0.080 |
Why?
| | Infant | 5 | 2024 | 10022 | 0.080 |
Why?
| | Risk Factors | 5 | 2023 | 10796 | 0.080 |
Why?
| | Health Services Administration | 1 | 2009 | 9 | 0.080 |
Why?
| | Internet | 2 | 2011 | 698 | 0.080 |
Why?
| | Health Promotion | 1 | 2016 | 771 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 355 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2008 | 3414 | 0.070 |
Why?
| | Young Adult | 2 | 2018 | 14119 | 0.070 |
Why?
| | Suction | 1 | 2009 | 32 | 0.070 |
Why?
| | Nursing Methodology Research | 2 | 2007 | 43 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3329 | 0.070 |
Why?
| | Demography | 1 | 2009 | 287 | 0.070 |
Why?
| | Curriculum | 3 | 2015 | 1063 | 0.070 |
Why?
| | Food Hypersensitivity | 1 | 2010 | 164 | 0.070 |
Why?
| | Scientific Misconduct | 1 | 2008 | 7 | 0.070 |
Why?
| | Delivery of Health Care | 2 | 2022 | 944 | 0.070 |
Why?
| | Canada | 5 | 2011 | 432 | 0.070 |
Why?
| | Quality Control | 1 | 2008 | 164 | 0.070 |
Why?
| | Risk | 1 | 2010 | 911 | 0.070 |
Why?
| | Databases as Topic | 1 | 2007 | 71 | 0.070 |
Why?
| | Information Services | 1 | 2007 | 43 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2009 | 5869 | 0.060 |
Why?
| | Health Status Indicators | 1 | 2007 | 167 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2011 | 1103 | 0.060 |
Why?
| | Circadian Rhythm | 5 | 1992 | 510 | 0.060 |
Why?
| | Family Practice | 2 | 2000 | 402 | 0.060 |
Why?
| | Employee Performance Appraisal | 1 | 2005 | 6 | 0.060 |
Why?
| | Informed Consent | 1 | 2007 | 197 | 0.060 |
Why?
| | Child Welfare | 1 | 2007 | 231 | 0.060 |
Why?
| | Seasons | 1 | 2008 | 556 | 0.050 |
Why?
| | Health Plan Implementation | 1 | 2006 | 141 | 0.050 |
Why?
| | Telephone | 1 | 2005 | 176 | 0.050 |
Why?
| | Counseling | 1 | 2007 | 405 | 0.050 |
Why?
| | Leukotriene Antagonists | 1 | 2004 | 23 | 0.050 |
Why?
| | Decision Making | 2 | 2011 | 973 | 0.050 |
Why?
| | Patient Admission | 1 | 2006 | 220 | 0.050 |
Why?
| | Health Surveys | 1 | 2006 | 517 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 2004 | 92 | 0.050 |
Why?
| | Europe | 1 | 2024 | 419 | 0.050 |
Why?
| | Financing, Organized | 1 | 2023 | 36 | 0.050 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.050 |
Why?
| | Vascular Patency | 1 | 2023 | 121 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 228 | 0.050 |
Why?
| | Internship and Residency | 1 | 2013 | 1262 | 0.050 |
Why?
| | Popliteal Artery | 1 | 2023 | 62 | 0.050 |
Why?
| | Patient Care Team | 1 | 2008 | 690 | 0.050 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 65 | 0.050 |
Why?
| | Theophylline | 4 | 1992 | 41 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 143 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2005 | 271 | 0.050 |
Why?
| | United States | 4 | 2023 | 16018 | 0.040 |
Why?
| | Faculty | 1 | 2023 | 153 | 0.040 |
Why?
| | Educational Status | 1 | 2004 | 463 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2023 | 11734 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 567 | 0.040 |
Why?
| | Femoral Artery | 1 | 2023 | 190 | 0.040 |
Why?
| | Focus Groups | 1 | 2004 | 566 | 0.040 |
Why?
| | Chronic Disease | 1 | 2007 | 1810 | 0.040 |
Why?
| | Spirometry | 2 | 2000 | 231 | 0.040 |
Why?
| | Obesity | 1 | 2015 | 3070 | 0.040 |
Why?
| | Self Efficacy | 1 | 2004 | 409 | 0.040 |
Why?
| | Guideline Adherence | 2 | 2008 | 586 | 0.040 |
Why?
| | Risk Assessment | 2 | 2007 | 3729 | 0.040 |
Why?
| | Physicians | 1 | 2009 | 949 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2004 | 477 | 0.040 |
Why?
| | Patient Compliance | 1 | 2004 | 587 | 0.040 |
Why?
| | Cooperative Behavior | 2 | 2015 | 464 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 894 | 0.040 |
Why?
| | Peer Group | 2 | 2011 | 256 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2000 | 537 | 0.040 |
Why?
| | Physicians, Family | 1 | 2000 | 173 | 0.040 |
Why?
| | Time Factors | 3 | 2007 | 7140 | 0.040 |
Why?
| | Health Status | 1 | 2004 | 834 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5414 | 0.030 |
Why?
| | Poverty | 1 | 2022 | 522 | 0.030 |
Why?
| | Mental Health | 1 | 2004 | 792 | 0.030 |
Why?
| | Critical Care | 1 | 2004 | 695 | 0.030 |
Why?
| | Cohort Studies | 1 | 2008 | 5957 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3147 | 0.030 |
Why?
| | Research Design | 1 | 2022 | 1129 | 0.030 |
Why?
| | Models, Educational | 1 | 2015 | 89 | 0.030 |
Why?
| | Capacity Building | 1 | 2015 | 62 | 0.030 |
Why?
| | Prospective Studies | 1 | 2007 | 7994 | 0.030 |
Why?
| | Research Support as Topic | 1 | 2015 | 79 | 0.030 |
Why?
| | Data Collection | 2 | 2009 | 635 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 200 | 0.030 |
Why?
| | Inflammation | 2 | 2004 | 2870 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6399 | 0.020 |
Why?
| | Histamine | 1 | 1991 | 53 | 0.020 |
Why?
| | Art | 1 | 2010 | 12 | 0.020 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1991 | 58 | 0.020 |
Why?
| | Public Policy | 1 | 2010 | 79 | 0.020 |
Why?
| | Risk Management | 1 | 2010 | 83 | 0.020 |
Why?
| | Psychology | 1 | 2010 | 88 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 2008 | 2942 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17147 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1991 | 175 | 0.020 |
Why?
| | Ethanolamines | 1 | 1989 | 14 | 0.020 |
Why?
| | Forced Expiratory Volume | 4 | 1992 | 448 | 0.020 |
Why?
| | Adrenergic Agonists | 1 | 2008 | 5 | 0.020 |
Why?
| | Social Behavior | 1 | 2011 | 287 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1991 | 297 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 322 | 0.020 |
Why?
| | Self Administration | 1 | 2008 | 124 | 0.020 |
Why?
| | Morale | 1 | 2007 | 5 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 368 | 0.020 |
Why?
| | Perception | 1 | 2010 | 376 | 0.020 |
Why?
| | Career Choice | 1 | 2009 | 233 | 0.020 |
Why?
| | Insurance, Health | 1 | 2009 | 308 | 0.020 |
Why?
| | Quality Improvement | 1 | 2015 | 1287 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1241 | 0.010 |
Why?
| | Forms and Records Control | 1 | 2006 | 20 | 0.010 |
Why?
| | Body Mass Index | 1 | 2015 | 2419 | 0.010 |
Why?
| | Acute Disease | 1 | 2008 | 1029 | 0.010 |
Why?
| | Education | 1 | 2006 | 105 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 480 | 0.010 |
Why?
| | Age Distribution | 1 | 2006 | 402 | 0.010 |
Why?
| | Sex Distribution | 1 | 2006 | 386 | 0.010 |
Why?
| | Emotions | 1 | 2010 | 578 | 0.010 |
Why?
| | Teaching | 1 | 2007 | 237 | 0.010 |
Why?
| | Double-Blind Method | 2 | 2006 | 2033 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 732 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1995 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2008 | 528 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2009 | 710 | 0.010 |
Why?
| | Oxygen | 1 | 2009 | 984 | 0.010 |
Why?
| | Databases, Factual | 1 | 2009 | 1494 | 0.010 |
Why?
| | Pharmacies | 1 | 2004 | 40 | 0.010 |
Why?
| | Patient Selection | 1 | 2007 | 727 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2007 | 461 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1742 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2008 | 852 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2004 | 283 | 0.010 |
Why?
| | Peak Expiratory Flow Rate | 2 | 1992 | 25 | 0.010 |
Why?
| | Methacholine Chloride | 2 | 1992 | 50 | 0.010 |
Why?
| | Bronchial Provocation Tests | 2 | 1992 | 47 | 0.010 |
Why?
| | Patient Readmission | 1 | 2006 | 765 | 0.010 |
Why?
| | Health Behavior | 1 | 2005 | 786 | 0.010 |
Why?
| | Sleep Stages | 2 | 1989 | 76 | 0.010 |
Why?
| | Lung | 1 | 1992 | 4089 | 0.010 |
Why?
| | Communication | 1 | 2005 | 972 | 0.010 |
Why?
| | Random Allocation | 2 | 1989 | 366 | 0.010 |
Why?
| | Delayed-Action Preparations | 2 | 1989 | 184 | 0.010 |
Why?
| | Sleep | 2 | 1991 | 890 | 0.010 |
Why?
| | Pindolol | 1 | 1991 | 2 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1991 | 36 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1991 | 29 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1991 | 182 | 0.010 |
Why?
| | Isoproterenol | 1 | 1991 | 96 | 0.010 |
Why?
| | Cell Count | 1 | 1991 | 320 | 0.000 |
Why?
| | Leukocyte Count | 1 | 1991 | 315 | 0.000 |
Why?
| | Methacholine Compounds | 1 | 1990 | 1 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1991 | 205 | 0.000 |
Why?
| | Cell Separation | 1 | 1991 | 303 | 0.000 |
Why?
| | Bronchoscopy | 1 | 1991 | 227 | 0.000 |
Why?
| | Leukocytes | 1 | 1991 | 294 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1989 | 79 | 0.000 |
Why?
| | Sodium Chloride | 1 | 1990 | 142 | 0.000 |
Why?
| | Pulmonary Gas Exchange | 1 | 1989 | 116 | 0.000 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1991 | 580 | 0.000 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1991 | 630 | 0.000 |
Why?
| | Bronchi | 1 | 1990 | 263 | 0.000 |
Why?
| | Administration, Oral | 1 | 1989 | 851 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1989 | 2019 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1989 | 1056 | 0.000 |
Why?
|
|
Cicutto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|